A novel ceRNA network involving MALAT1/miR-30b/CNR1 can increase neuronal viability and reduce neuronal damage by Aβ in AD cells and animal models in which the PI3K/AKT signaling pathway is activated [190]. The gene discussed is AKT1; the disease is Alzheimer disease.